Mary M. Moran
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 7
- COVID-19 Clinical Research Studies 5
- Parasitology top 5%
- Modeling and Simulation top 5%
- Health top 10%
- Vaccine Coverage and Hesitancy 6
-
- Respiratory viral infections research 6
-
- Health Systems, Economic Evaluations, Quality of Life 4
- Pharmaceutical Economics and Policy 4
-
- Kawasaki Disease and Coronary Complications 3
-
- Biotechnology and Related Fields 3
Mary M. Moran
27 papers receiving 615 citations
Peers
Comparison fields: 5 of 105
- Business and International Management 25
- Infectious Diseases 218
- Parasitology 74
- Modeling and Simulation 46
- Health 78
Countries citing papers authored by Mary M. Moran
This map shows the geographic impact of Mary M. Moran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary M. Moran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary M. Moran more than expected).
Fields of papers citing papers by Mary M. Moran
This network shows the impact of papers produced by Mary M. Moran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary M. Moran. The network helps show where Mary M. Moran may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mary M. Moran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 12 | |
| 4 | 2023 | 49 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 20 | |
| 8 | 2023 | 22 | |
| 9 | 2022 | 24 | |
| 10 | 2020 | 8 | |
| 11 | 2016 | 9 | |
| 12 | 2014 | 2 | |
| 13 | 2011 | 31 | |
| 14 | 2009 | 165 | |
| 15 | 2005 | 113 | |
| 16 | 2005 | 1 | |
| 17 | 2004 | 10 | |
| 18 | 2003 | 3 | |
| 19 | 2001 | 6 | |
| 20 | 1999 | 21 |
About Mary M. Moran
Mary M. Moran is a scholar working on Health, Infectious Diseases and Modeling and Simulation, having authored 31 papers that have together received 647 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), Respiratory viral infections research (6 papers), Vaccine Coverage and Hesitancy (6 papers), COVID-19 Clinical Research Studies (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Pharmaceutical Economics and Policy (4 papers), Kawasaki Disease and Coronary Complications (3 papers) and Biotechnology and Related Fields (3 papers). The work is most often cited by research in Business and International Management (25 citations), Infectious Diseases (218 citations) and Parasitology (74 citations). Mary M. Moran has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Lindsey Wu, Javier Guzmán, Nicole Jameson, Manuela Di Fusco, Alejandro Cané, Jennifer L. Nguyen, J. Jeffrey Malatack, Jay Lin, Santiago M. C. Lopez and Farid Khan. Their work appears in journals such as PLoS Medicine, Journal of Medical Economics, Frontiers in Pediatrics, Advances in Therapy and Human Vaccines & Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.